Amphoraxe Life Sciences Inc.
Amphoraxe Life Sciences Inc.
  • Home
  • Our Story
  • Team
  • Technology
  • News
  • Jobs
  • More
    • Home
    • Our Story
    • Team
    • Technology
    • News
    • Jobs

  • Home
  • Our Story
  • Team
  • Technology
  • News
  • Jobs

It started with frogs.


The Amphoraxe story began in the Birol Lab at BC Cancer’s Genome Sciences Centre. In 2013, Amphoraxe Co-Founder Dr. Inanç Birol collaborated with Dr. Caren Helbing (University of Victoria) on a basic research project to sequence the genome of the North American bullfrog (Rana [Lithobates] catesbeiana). Frogs are some of the most prolific sources of antimicrobial peptides (AMPs) identified to date, and the initial research project discovered many novel potential AMPs. 


A growing academic collaboration led by Dr. Birol has continued to identify and improve bullfrog AMPs ever since, with funding support from Genome Canada and Genome British Columbia. Most recently, the team received a $6.9 M investment from Genome Canada and Genome British Columbia as part of the Large-Scale Applied Research Project funding scheme.


Amphoraxe Life Sciences Inc. was created in 2019 to optimize and commercialize the most promising AMPs identified by our academic partners. The Amphoraxe team also continues to rapidly identify and improve additional candidate AMPs, as ongoing innovation will be necessary to counter the moving target of antibiotic resistance. 


Scholarly Publications


  • Models and data of AMPlify: a deep learning tool for antimicrobial peptide prediction. BMC Res Notes 2023
  • Associating Biological Activity and Predicted Structure of Antimicrobial Peptides from Amphibians and Insects. Antibiotics (Basel) 2022
  • Mining Amphibian and Insect Transcriptomes for Antimicrobial Peptide Sequences with rAMPage. Antibiotics (Basel) 2022
  • AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens. BMC Genomics 2022
  • Antimicrobial peptides from Rana [Lithobates] catesbeiana: Gene structure and bioinformatic identification of novel forms from tadpoles. Scientific Reports 2019
  • The North American bullfrog draft genome provides insight into hormonal regulation of long noncoding RNA. Nature Communications 2017
  • De novo Transcriptome Assemblies of Rana (Lithobates) catesbeiana and Xenopus laevis Tadpole Livers for Comparative Genomics without Reference Genomes. PLoS One 2015


Please see Inanç Birol's Google Scholar profile for additional Birol Lab publications.

Connect With Us

Amphoraxe Life Sciences Inc., A BC Company

4103 Parkway Dr, Vancouver, BC V6L 3C9, Canada

(778) 893-4042 info@amphoraxe.ca

Copyright © 2023 Amphoraxe Life Sciences Inc.- All Rights Reserved. 


Amphoraxe acknowledges that we are situated on the traditional, ancestral, and unceded territories of the xʷməθkʷəy̓əm (Musqueam), Sḵwx̱wú7mesh (Squamish), and səl̓ílwətaɬ (Tsleil-Waututh) Nations.

Cookie Policy

This website uses cookies. By continuing to use this site, you accept our use of cookies.

Accept & Close